Patent ID: 9458192
Filing Date: 2016-10-04
CPC Classification: A61K,C07K

Claim Text:
1. A compound selected from the group consisting of (S)-3-{[1-{2-[(2S,3S)-2-(3-carboxypropanamido)-3-methylpentanamido]acetyl}-2,3-dihydro-1H-indol-2-yl]formamido}-4-oxobutanoic acid; 3-{[(2S)-1-(2-acetamidoacetyl)-2,3-dihydro-1H-indol-2-yl]formamido}-4-oxobutanoic acid; (S)-3-{[(2S)-1-{2-[(2S,3S)-3-methyl-2-[2-(2H-1,2,3,4-tetrazol-5-yl)acetamido]pentanamido]acetyl}-1H,2H,3H-pyrrolo[2,3-b]pyridin-2-yl]formamido}-4-oxobutanoic acid; (S)-4-(benzylcarbamoyl)-3-{[(2S)-1-{2-[(2S,3S)-3-methyl-2-[2-(2H-1,2,3,4-tetrazol-5-yl)acetamido]pentanamido]acetyl}-2,3-dihydro-1H-indol-2-yl]formamido}-4-oxobutanoic acid; (S)-3-{[(2S)-1-{2-[(2S,3 S)-3-methyl-2-[2-(2H-1,2,3,4-tetrazol-5-yl)acetamido]pentanamido]acetyl}-2,3-dihydro-1H-indol-2-yl]formamido}-4-(methylcarbamoyl)-4-oxobutanoic acid; (S)-5-chloro-3-{[1-{2-[(2S,3S)-3-methyl-2-[2-(2H-1,2,3,4-tetrazol-5-yl)acetamido]pentanamido]acetyl}-2,3-dihydro-1H-indol-2-yl]formamido}-(S)-4-oxopentanoic acid; (S)-3-{[1-[(2S)-2-[(2S,3S)-2-(6-{5-[(3aS,4S,6aR)-2-oxo-hexahydro-1H-thieno[3,4-d]imidazolidin-4-yl]pentanamido}hexanamido)-3-methylpentanamido]-4-carboxybutanoyl]-1H,2H,3H-pyrrolo[2,3-b]pyridin-2-yl]formamido}-5-chloro-(S)-4-oxopentanoic acid; and stereoisomers, tautomers, and pharmaceutically acceptable salts thereof.